TCM
PYXS icon

Tang Capital Management’s Pyxis Oncology PYXS Stock Holding History

Tang Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,500,000
Closed -$5.55M – 164
2025
Q3 		$5.55M Hold
2,500,000
– – 0.21% 92
2025
Q2 		$2.75M Buy
2,500,000
+1,400,000
+127% +$1.58M 0.14% 111
2025
Q1 		$1.08M Buy
+1,100,000
New +$1.47M 0.06% 149
2023
Q3 		– Sell
-1,787,775
Closed -$4.58M – 113
2023
Q2 		$4.58M Sell
1,787,775
-693,887
-28% -$2.2M 0.67% 41
2023
Q1 		$9.95M Sell
2,481,662
-989,038
-28% -$1.98M 1.48% 22
2022
Q4 		$4.65M Buy
3,470,700
+2,059,131
+146% +$3.09M 0.68% 37
2022
Q3 		$2.78M Buy
1,411,569
+32,489
+2% +$84.9K 0.34% 63
2022
Q2 		$3.28M Buy
+1,379,080
New +$3.67M 0.5% 38

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tang Capital Management's PYXS Position: Q4 2025 in Review

Tang Capital Management sold out of Pyxis Oncology (PYXS) in Q4 2025, closing a stake of 2,500,000 shares — an estimated $5.55M sold.

Tang Capital Management first reported a position in PYXS in Q2 2022 and held it in 8 quarters. The position peaked at $9.95M in Q1 2023. 79 funds tracked by Wall St. Rank hold PYXS as of Q4 2025.

  • Tang Capital Management reported no remaining Pyxis Oncology position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 2,500,000 Pyxis Oncology shares in Q4 2025, an estimated $5.55M.
  • Tang Capital Management first reported a position in Pyxis Oncology in Q2 2022 and held it in 8 quarters.
  • Tang Capital Management's Pyxis Oncology position peaked at $9.95M in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.